ArticleBioscience reports2026

SGLT2 inhibitor ameliorates hypertension by regulating the CYP4A/20-HETE pathway in the kidney.

Zhitong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.